Introduction: Delays in door to skin puncture time for patients with ischemic stroke are associated with worse clinical outcomes. The following quality improvement study was conducted at Greenwich Hospital which aimed to decrease door to skin puncture time for endovascular stroke treatment. Greenwich Hospital began its new stroke program in January 2020 and opened thrombectomy capable interventional radiology (IR) services. Delays to door to skin puncture times existed with average time being 100 minutes with a goal time of 90 minutes or less for 50% or more of patients directly arriving to the hospital and 60 minutes or less for 50% or more of patients transferred from another hospital. Materials and Methods: Our stroke team implemented a...
Objective: Ischemic strokes cause significant morbidity and mortality. Treatment with tissue plasmin...
Explaining the risks and benefits of recombinant tissue-plasminogen activator (rtPA) to eligible pat...
Despite international consensus on the benefits of thrombolysis for ischaemic stroke (IS), it remain...
Introduction: Due to the large number of endovascular-eligible acute ischemic stroke patients, the u...
Background-—Delays to intra-arterial therapy (IAT) lead to worse outcomes in stroke patients with pr...
Background-—Delays to intra-arterial therapy (IAT) lead to worse outcomes in stroke patients with pr...
Thrombolysis is associated with reduced disability for selected patients who have suffered ischemic ...
Objective: To reduce door-to-angiographic reperfusion (DTR) time to 120 minutes for patients present...
BACKGROUND AND PURPOSE: Intravenous thrombolysis is a well-established treatment for acute ischemic ...
BACKGROUND AND PURPOSE: Intravenous thrombolysis is a well-established treatment for acute ischemic ...
BACKGROUND: This study aims to evaluate the effectiveness of implementing a stroke protocol (SP) in ...
BACKGROUND: This study aims to evaluate the effectiveness of implementing a stroke protocol (SP) in ...
BACKGROUND: This study aims to evaluate the effectiveness of implementing a stroke protocol (SP) in ...
BACKGROUND: This study aims to evaluate the effectiveness of implementing a stroke protocol (SP) in ...
BACKGROUND: In acute stroke due to large vessel occlusion, faster reperfusion leads to better outcom...
Objective: Ischemic strokes cause significant morbidity and mortality. Treatment with tissue plasmin...
Explaining the risks and benefits of recombinant tissue-plasminogen activator (rtPA) to eligible pat...
Despite international consensus on the benefits of thrombolysis for ischaemic stroke (IS), it remain...
Introduction: Due to the large number of endovascular-eligible acute ischemic stroke patients, the u...
Background-—Delays to intra-arterial therapy (IAT) lead to worse outcomes in stroke patients with pr...
Background-—Delays to intra-arterial therapy (IAT) lead to worse outcomes in stroke patients with pr...
Thrombolysis is associated with reduced disability for selected patients who have suffered ischemic ...
Objective: To reduce door-to-angiographic reperfusion (DTR) time to 120 minutes for patients present...
BACKGROUND AND PURPOSE: Intravenous thrombolysis is a well-established treatment for acute ischemic ...
BACKGROUND AND PURPOSE: Intravenous thrombolysis is a well-established treatment for acute ischemic ...
BACKGROUND: This study aims to evaluate the effectiveness of implementing a stroke protocol (SP) in ...
BACKGROUND: This study aims to evaluate the effectiveness of implementing a stroke protocol (SP) in ...
BACKGROUND: This study aims to evaluate the effectiveness of implementing a stroke protocol (SP) in ...
BACKGROUND: This study aims to evaluate the effectiveness of implementing a stroke protocol (SP) in ...
BACKGROUND: In acute stroke due to large vessel occlusion, faster reperfusion leads to better outcom...
Objective: Ischemic strokes cause significant morbidity and mortality. Treatment with tissue plasmin...
Explaining the risks and benefits of recombinant tissue-plasminogen activator (rtPA) to eligible pat...
Despite international consensus on the benefits of thrombolysis for ischaemic stroke (IS), it remain...